Abiopharma

Artelo Biosciences Names Veteran Life Sciences Executive Mark Spring, CPA, as Chief Financial Officer

STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon

BioNTech veröffentlicht am 3. November 2025 Ergebnisse für das dritte Quartal 2025 und informiert über operativen Fortschritt

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

MLTX INVESTOR NOTICE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

DocGo to Announce Third Quarter 2025 Results on Monday, November 10, 2025

BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers

Icotrokinra maintains standout combination of therapeutic benefit and a favorable safety profile in once-daily pill through 28 weeks in ulcerative colitis

Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z)

Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call